MDXG FY 2013 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$677M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+118.8% YoY

Gross Profit

$50M84.2% margin

Operating Income

-$3M-4.5% margin

Net Income

-$4M-6.9% margin

EPS (Diluted)

$-0.04

Cash Flow

Operating Cash Flow

-$285,477

Free Cash Flow

-$3M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$85M

Total Liabilities

$11M

Stockholders' Equity

$74M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$27M	+118.8%
Gross Profit	$50M	$22M	+128.0%
Operating Income	-$3M	-$2M	-32.5%
Net Income	-$4M	-$8M	+46.3%